Results 181 to 190 of about 25,572 (194)
Some of the next articles are maybe not open access.
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Nature Reviews Microbiology, 2009Lanying Du, Yuxian He, Yusen Zhou
exaly
Biotechnological Potential of Ribosome Inactivating Proteins (RIPs)
2015DI MARO, Antimo, Pizzo E., Girbes T.
openaire +2 more sources
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Nature Reviews Drug Discovery, 2016Duncan E Scott +2 more
exaly
AMP-activated protein kinase: the current landscape for drug development
Nature Reviews Drug Discovery, 2019Gregory R Steinberg, David Carling
exaly
Multiple Myeloma: An Old Disease with New Hope for the Future
Ca-A Cancer Journal for Clinicians, 2001exaly
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Nature Reviews Molecular Cell Biology, 2007exaly
RicinA Type II Ribosome-Inactivating Protein
2009Robert N. Brey, Nicholas J. Mantis
openaire +1 more source

